Helio Genomics Presents Four Studies at the San Antonio Liver Cancer Symposium
Posters explore whether HelioLiver™ Dx can flag hepatocellular carcinoma when ultrasound is negative, imaging is indeterminate, or a tumor is not yet visible SAN ANTONIO, Oct. 9, 2026 /PRNewswire/ -- Helio Genomics today announced four poster presentations at the San Antonio Liver Cancer...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.